← All Posts
TRA
TransMedics Group, Inc.
May 21, 2026
•
Author: Phil Ratcliff
| Item |
Proposal |
Vote |
| 1 |
Election of Directors |
|
| 1a |
Waleed H. Hassanein, M.D. |
Withhold(183.904)
|
| 1b |
James R. Tobin |
✓ For(183.904)
|
| 1c |
Edward M. Basile |
✓ For(183.904)
|
| 1d |
Thomas J. Gunderson |
✓ For(183.904)
|
| 1e |
Edwin M. Kania, Jr. |
✓ For(183.904)
|
| 1f |
Stephanie Lovell |
✓ For(183.904)
|
| 1g |
Merilee Raines |
✓ For(183.904)
|
| 1h |
David Weill, M.D. |
✓ For(183.904)
|
| 2 |
To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers. |
✓ For(183.904)
|
| 3 |
To approve an amendment to the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan by 2,750,000 shares and make certain other changes as set forth in the proxy statement. |
✓ For(183.904)
|
| 4 |
To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. |
✓ For(183.904)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.
rebel Financial